• Investing Ideas
  • /
  • Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Header cover image

Global Pharmaceuticals & Biotech Potentially Undervalued Companies

Companies with a Value score of at least 3, ordered by Value score

1,199 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
SUPNSupernus PharmaceuticalsUS$30.688.0%53.1%US$1.6bUS$34.33PE16.3xE16.5%n/a
GNML.FGenomma Lab Internacional. deUS$0.990%n/aUS$19.6bUS$1.33PE13.7xE17.1%n/a
GEKAGenomma Lab Internacional. de€0.791.3%-8.7%€19.6b€1.05PE13.7xE17.1%n/a
UTHUnited Therapeutics€160.00-4.8%63.3%€8.4b€198.33PE17.8xE22.0%n/a
UTHRUnited TherapeuticsUS$184.32-4.5%58.3%US$8.3bUS$231.89PE17.6xE22.0%n/a
XLSXlife Sciences€48.40-0.4%30.1%€236.7mn/aPE18.1xE69.6%n/a
XLSXlife Sciences€47.60-2.1%28.0%€236.7mn/aPE18.1xE69.6%n/a
82PPacira BioSciences€46.6012.0%-1.7%€2.4b€69.56PE13.6xE21.2%n/a
BD5BioDelivery Sciences International€3.34-3.5%6.4%€395.4m€6.22PE11.7xE39.4%n/a
PHARMPharming Group€0.790.2%-15.4%€508.5m€2.16PE19xE34.8%n/a
SAGESage TherapeuticsUS$44.07-2.6%-36.8%US$2.6bUS$79.40PE3.9xE25.8%n/a
SG7Sage Therapeutics€39.321.2%-33.7%€2.6b€69.47PE4xE25.8%n/a
SG7Sage Therapeutics€38.240%-34.1%€2.6b€67.56PE4xE25.8%n/a
2332Zhejiang Xianju PharmaceuticalLtdCN¥10.33-7.2%-37.4%CN¥10.2bn/aPE17.8xE22.4%1.5%
2332Zhejiang Xianju PharmaceuticalLtdCN¥10.67-4.1%-35.3%CN¥10.6bn/aPE18.4xE22.4%1.4%
300463Maccura BiotechnologyLtdCN¥27.55-5.3%-50.3%CN¥15.3bCN¥51.30PE15.1xE19.1%1.6%
300463Maccura BiotechnologyLtdCN¥28.88-0.7%-47.9%CN¥16.1bCN¥51.30PE15.8xE19.1%1.5%
1762Chunghwa Chemical Synthesis & BiotechNT$67.40-13.8%7.8%NT$5.2bNT$92.33PE14.6xE38.7%2.2%
S2PSimcere Pharmaceutical Group€0.833.8%n/a€20.8b€1.35PE16.5xE21.8%2.3%
600216Zhejiang MedicineCN¥16.08-5.4%6.5%CN¥15.4bCN¥24.15PE19.3xE21.0%1.4%
600216Zhejiang MedicineCN¥15.97-6.0%5.8%CN¥15.3bCN¥24.15PE19.2xE21.0%1.4%
HLUY.YH. LundbeckUS$27.16-0.6%-11.7%US$34.6bUS$35.67PE17.6xE27.2%1.4%
HLUK.FH. LundbeckUS$28.206.9%-9.6%US$34.6bUS$37.04PE17.6xE27.2%1.4%
C1PConsun Pharmaceutical Group€0.36-4.2%6.5%€2.7bn/aPE4.2xE12.1%8.9%
Page 1 of 50